The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, May 9, 2006
163

Emergency Department STD and HIV Screening: Findings from a National Survey

Thomas L. Gift, Division of STD Prevention, CDC, Atlanta, GA, USA and Matthew Hogben, Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mail Stop E-44, Atlanta, GA, USA.


Background:
Numerous studies have documented that ED patients have higher STD rates than prevail in their communities overall, and survey data show that a substantial proportion of STD patients are treated in EDs. Because of these factors, cost-effectiveness analyses have shown that STD screening in EDs can be cost-effective. HIV screening is also recommended for ED patients. Surveys of ED physicians have shown that barriers to screening include time constraints and follow-up concerns.

Objective:
To use a national physician survey conducted in 1999 (4226 responses, response rate 70.2%) to determine the extent of STD and HIV screening by ED physicians compared to physicians not practicing in EDs.

Method:
We determined the percent of ED and non-ED physicians screening for each of syphilis, gonorrhea, chlamydia, and HIV from the survey. The survey did not have patient-level data. We used data for practice location, physician gender, and patient demographics of race and gender from the survey in multivariate logistic regressions to determine adjusted odds ratios.

Result:
ED physicians were less likely than non-ED physicians to screen for syphilis, gonorrhea, chlamydia, and HIV in all patient groups (men, non-pregnant women, and pregnant women). Among ED physicians, screening rates ranged from 5.2% for HIV in women (versus 22.9% of non-ED physicians) to 26.9% in women for chlamydia (versus 37% of non-ED physicians). The differences in screening rates were significant at p < 0.05 except in men for chlamydia and gonorrhea. The adjusted ORs varied from 0.103 (for HIV screening of pregnant women) to 0.926 (for chlamydia screening of men).

Conclusion:
ED physicians screen for STDs and HIV less frequently than providers in other settings, despite studies showing that ED patients are at elevated risk for STDs and HIV.

Implications:
Programs should seek to increase ED clinicians' acceptance of and ability to conduct STD and HIV screening.